AstraZeneca enters late-stage COVID-19 vaccine trial

Multinational pharmaceutical company AstraZeneca announced it has started Phase III clinical trials in the United States of its COVID-19 candidate vaccine.

from Latest News - UPI.com https://ift.tt/3hKLB7G
via IFTTT